By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CVie Therapeutics Limited 



Tainan      Taiwan
Phone: n/a Fax: n/a


SEARCH JOBS

CVie Therapeutics Limited is a Taiwan-based joint venture founded in 2013 by Lee's Pharmaceutical Holdings Limited and renowned venture capitals from the US and Taiwan. It is a stand-alone drug development company specialized in cardiovascular diseases. CVie currently owns two phase IIb assets that target cardiovascular diseases with significant unmet medical need. Rostafuroxin is a novel precision medicine targeting hypertensive patients with certain genetic profiles with better efficacy and safety than conventional therapies. Istaroxime is a first-in-class luso-inotropic medicine for the treatment of acute heart failure and will have fewer adverse effects than conventional inotropes, namely, increased heart rate, arrhythmia, increased oxygen consumption, hypotension, etc.

YEAR FOUNDED:

2013

LEADERSHIP:

CEO: Dr. Benjamin Li

COO: Lit-Fui Lau



Key Statistics


Email:
Ownership: Subsidiary

Web Site: CVie Therapeutics Limited
Employees:
Symbol: LPHM
 



Industry
Biotechnology






Company News
//-->